This article has been updated from a previous version, which incorrectly identified the location of Atria's headquarters.
 
NEW YORK (GenomeWeb News) - Celera said today that it plans to acquire Atria Genetics in a $33 million cash deal that is expected to add transplant-related testing to the company’s molecular diagnostics portfolio.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.